Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma.
- DOI
- 10.1007/s40262-025-01538-9
- Published
- 2025 Aug
- Container
- Clinical pharmacokinetics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40262-025-01538-9,
title = {Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma.},
author = {Jin Y and Guiastrennec B and Stuke M and Yao Y and Zhang Y and Barker P and Jison M and Penland RC and Ding J and Lukka PB},
year = {2025},
journal = {Clinical pharmacokinetics},
doi = {10.1007/s40262-025-01538-9},
url = {https://doi.org/10.1007/s40262-025-01538-9}
}RIS
TY - JOUR TI - Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma. AU - Jin Y AU - Guiastrennec B AU - Stuke M AU - Yao Y AU - Zhang Y AU - Barker P AU - Jison M AU - Penland RC AU - Ding J AU - Lukka PB PY - 2025 JO - Clinical pharmacokinetics DO - 10.1007/s40262-025-01538-9 UR - https://doi.org/10.1007/s40262-025-01538-9 ER -
APA
Y, J., B, G., M, S., Y, Y., Y, Z., P, B., M, J., RC, P., J, D., & PB, L. (2025). Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma.. Clinical pharmacokinetics. https://doi.org/10.1007/s40262-025-01538-9
Source records
- pubmed · retrieved 2026-09-25T18:45:03.011Z